| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007258940 |
| P356 | DOI | 10.1007/S11926-000-0021-Y |
| P698 | PubMed publication ID | 11123098 |
| P2093 | author name string | Goldring MB | |
| P2860 | cites work | Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins | Q22009926 |
| Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family | Q22010479 | ||
| TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha | Q24313203 | ||
| Interleukin-1 receptor antagonist: role in biology | Q28271409 | ||
| The interleukin 1 receptor: ligand interactions and signal transduction | Q28295124 | ||
| Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. | Q30807179 | ||
| New targets for anti-inflammatory drugs | Q33695752 | ||
| Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments | Q33753617 | ||
| Cytokines and their role in the pathophysiology of osteoarthritis | Q33753628 | ||
| An introduction to the pathophysiology of osteoarthritis | Q33753632 | ||
| Degradative enzymes in osteoarthritis. | Q33753639 | ||
| The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards? | Q33782321 | ||
| Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction | Q33782333 | ||
| The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models | Q33894450 | ||
| Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases | Q33922157 | ||
| The role of the chondrocyte in osteoarthritis | Q34051076 | ||
| Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. | Q34474493 | ||
| Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis | Q35547255 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. | Q35549401 | ||
| Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage | Q40814825 | ||
| Role of morphogenetic proteins in skeletal tissue engineering and regeneration | Q40864602 | ||
| Cytokines in osteoarthritis: mediators or markers of joint destruction? | Q41133438 | ||
| Lessons for joint destruction from animal models | Q41515683 | ||
| IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis | Q41751469 | ||
| Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways | Q42470898 | ||
| Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts | Q42481831 | ||
| Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice | Q42840040 | ||
| Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model | Q43854219 | ||
| Gene therapy for rheumatic diseases | Q45855770 | ||
| Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. | Q45862676 | ||
| In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy | Q45882179 | ||
| Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone | Q47996975 | ||
| Comparative study of serum and synovial fluid interleukin-11 levels in patients with various arthritides. | Q52228131 | ||
| Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies | Q71339960 | ||
| Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis | Q71503443 | ||
| Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis | Q73374754 | ||
| The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis | Q73414195 | ||
| Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1) | Q73574480 | ||
| Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture | Q73669005 | ||
| Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis | Q73820790 | ||
| Articular cartilage repair and transplantation | Q77093059 | ||
| Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses | Q77477157 | ||
| The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells | Q77755017 | ||
| IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses | Q77899699 | ||
| Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis | Q77909427 | ||
| Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage | Q77993335 | ||
| The regulation of MMPs and TIMPs in cartilage turnover | Q78027218 | ||
| Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone | Q78074203 | ||
| Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18 | Q78124693 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| cartilage | Q502730 | ||
| P304 | page(s) | 459-465 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Osteoarthritis and cartilage: the role of cytokines | |
| P478 | volume | 2 |
| Q35718396 | 75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes |
| Q35028071 | A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis |
| Q35952166 | A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes |
| Q37843041 | A mini-review: microRNA in arthritis |
| Q37104441 | A painful interface between normal aging and disease |
| Q38827337 | A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria |
| Q24608533 | A systems biology approach to synovial joint lubrication in health, injury, and disease |
| Q90569770 | Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats |
| Q42096174 | Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage |
| Q41785351 | Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee |
| Q36406029 | Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenc |
| Q40878851 | An assessment of the chondroprotective effects of intra-articular application of statin and tetracycline on early-stage experimental osteoarthritis |
| Q98289064 | Anti-Inflammatory Effects of Fermented Bark of Acanthopanax sessiliflorus and Its Isolated Compounds on Lipopolysaccharide-Treated RAW 264.7 Macrophage Cells |
| Q91809110 | Anti-Inflammatory and Anticancer Properties of Bioactive Compounds from Sesamum indicum L.-A Review |
| Q35102739 | Anti-Inflammatory mechanisms of the proteinase-activated receptor 2-inhibiting peptide in human synovial cells |
| Q26862600 | Anti-inflammatory strategies in cartilage repair |
| Q59113556 | Application of Gold Nanoparticles of Different Concentrations to Improve the Therapeutic Potential of Autologous Conditioned Serum: Potential Implications for Equine Regenerative Medicine |
| Q24805351 | Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis |
| Q54318379 | Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. |
| Q37595305 | Berberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling |
| Q24816745 | Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review |
| Q37082987 | Blockade of hypoxia-induced CXCR4 with AMD3100 inhibits production of OA-associated catabolic mediators IL-1β and MMP-13 |
| Q35910643 | Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration |
| Q97524981 | Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis |
| Q53652096 | Bornyl acetate has an anti-inflammatory effect in human chondrocytes via induction of IL-11. |
| Q36295868 | Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synovium |
| Q37272126 | Bovine lactoferricin-induced anti-inflammation is, in part, via up-regulation of interleukin-11 by secondary activation of STAT3 in human articular cartilage |
| Q38288005 | CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. |
| Q36143375 | CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2. |
| Q38650698 | Carprofen inhibits the release of matrix metalloproteinases 1, 3, and 13 in the secretome of an explant model of articular cartilage stimulated with interleukin 1β. |
| Q35840709 | Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis |
| Q34439709 | Cell biology of osteoarthritis: the chondrocyte's response to injury |
| Q96816576 | Characteristics of autologous protein solution and leucocyte-poor platelet-rich plasma for the treatment of osteoarthritis of the knee |
| Q36328400 | Characterization of degenerative human facet joints and facet joint capsular tissues |
| Q39641161 | Chondro-protective effects of low intensity pulsed ultrasound. |
| Q88890180 | Chondrocyte and mesenchymal stem cell derived engineered cartilage exhibits differential sensitivity to pro-inflammatory cytokines |
| Q34188301 | Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate |
| Q30651587 | Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES). |
| Q47339141 | Cue-Signal-Response Analysis in 3D Chondrocyte Scaffolds with Anabolic Stimuli |
| Q42732233 | Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro |
| Q44093807 | Curcumin: A Review of Its' Effects on Human Health |
| Q39243652 | Cytokines in healthy temporomandibular joint synovial fluid |
| Q38113846 | Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research |
| Q33615549 | Development and retranslational validation of an in vitro model to characterize acute infections in large human joints |
| Q36241217 | Diet and exercise for obese adults with knee osteoarthritis |
| Q46898604 | Disordered glycometabolism involved in pathogenesis of Kashin-Beck disease, an endemic osteoarthritis in China |
| Q37605537 | Do gene expression changes in articular cartilage proteases of the synovial membrane correlate with expression changes of the same genes in systemic blood cells? |
| Q35736650 | Does intra-articular fracture change the lubricant content of synovial fluid? |
| Q24793070 | Does protein kinase R mediate TNF-alpha- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? |
| Q37029663 | Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee |
| Q42650409 | Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of a post-traumatic chondral defect of the knee. |
| Q53539498 | Effect of microRNA-145 on IL-1β-induced cartilage degradation in human chondrocytes. |
| Q46960081 | Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study |
| Q55361972 | Effects of salmon DNA fraction in vitro and in a monosodium iodoacetate-induced osteoarthritis rat model. |
| Q92767392 | Endothelial proteolytic activity and interaction with non-resorbing osteoclasts mediate bone elongation |
| Q44124056 | Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor |
| Q44266578 | Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes |
| Q36042449 | Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes. |
| Q35574987 | Epigenetics and Osteoarthritis |
| Q44141078 | Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription |
| Q79676737 | Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation |
| Q24657447 | Expression of MicroRNA-146a in osteoarthritis cartilage |
| Q53830671 | Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes |
| Q90655869 | Extracellular matrix turnover and inflammation in chemically-induced TMJ arthritis mouse models |
| Q27025275 | Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases |
| Q88523823 | GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain |
| Q42708538 | Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice |
| Q48140227 | Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis |
| Q40108736 | Hoffa's Fat Pad Abnormality in the Development of Knee Osteoarthritis. |
| Q36641543 | Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. |
| Q39140776 | Hyperbaric oxygen protects mandibular condylar chondrocytes from interleukin-1β-induced apoptosis via the PI3K/AKT signaling pathway |
| Q45958044 | Hyperintense signal alteration in the suprapatellar fat pad on MRI is associated with degeneration of the patellofemoral joint over 48 months: data from the Osteoarthritis Initiative. |
| Q84285592 | Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction |
| Q47205934 | Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes |
| Q60909957 | Identification of Chondrocyte Genes and Signaling Pathways in Response to Acute Joint Inflammation |
| Q38027919 | Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine. |
| Q64101102 | In vitro chondroprotective potential of Senna alata and Senna tora in porcine cartilage explants and their species differentiation by DNA barcoding-high resolution melting (Bar-HRM) analysis |
| Q44733819 | Increased levels of IL-6, IL-1β, and TNF-α in Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency |
| Q36245974 | Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage |
| Q53442608 | Inflammatory response of cultured rat synoviocytes challenged with synovial fluid from osteoarthritis patients correlates with their radiographic grading: a pilot study. |
| Q39135449 | Interleukin-1 inhibits osmotically induced calcium signaling and volume regulation in articular chondrocytes |
| Q51758619 | Interplay of Inflammatory Mediators with Epigenetics and Cartilage Modifications in Osteoarthritis. |
| Q47820023 | Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis |
| Q35552093 | Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development |
| Q39839191 | Investigation of selected biochemical indicators of Equine Rhabdomyolysis in Arabian horses: pro-inflammatory cytokines and oxidative stress markers |
| Q37387755 | Involvement of the cytoskeletal elements in articular cartilage homeostasis and pathology |
| Q36013306 | Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study. |
| Q67496226 | Joint problems arising from lack of repair mechanisms: can cannabinoids help? |
| Q41482297 | Kaempferol Alleviates the Interleukin-1β-Induced Inflammation in Rat Osteoarthritis Chondrocytes via Suppression of NF-κB. |
| Q46063783 | Lidocaine potentiates the chondrotoxicity of methylprednisolone. |
| Q34625461 | Links between osteoarthritis and diabetes: implications for management from a physical activity perspective |
| Q51099342 | Location and gene-specific effects of methylprednisolone acetate on mitigating IL1β-induced inflammation in mature ovine explant knee tissue. |
| Q49668468 | Long-term Effect of Injection Treatment for Osteoarthritis in the Knee by Orthokin Autologous Conditioned Serum. |
| Q35145673 | Low-level laser therapy prevents degenerative morphological changes in an experimental model of anterior cruciate ligament transection in rats. |
| Q41459321 | Mathematical modelling of cytokines, MMPs and fibronectin fragments in osteoarthritic cartilage. |
| Q38317248 | Matrix-embedded cytokines to simulate osteoarthritis-like cartilage microenvironments |
| Q38584496 | Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor |
| Q33610520 | Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. |
| Q26745714 | Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review |
| Q36903284 | MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes |
| Q33588972 | MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses |
| Q91666950 | Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques |
| Q53535858 | Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. |
| Q90911117 | Multi-tissue network analysis for drug prioritization in knee osteoarthritis |
| Q37701897 | NF-kappaB signaling: multiple angles to target OA. |
| Q92914343 | NF-κB Phosphorylation Inhibition Prevents Articular Cartilage Degradation in Osteoarthritis Rats via 2-Aminoquinoline |
| Q36515489 | New findings in osteoarthritis pathogenesis: therapeutic implications. |
| Q37001372 | Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management |
| Q33900522 | Osteoarthritic cartilage explants affect extracellular matrix production and composition in cocultured bone marrow-derived mesenchymal stem cells and articular chondrocytes |
| Q99545920 | Osteoarthritis: Prognosis and emerging therapeutic approach for disease management |
| Q45881243 | Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation |
| Q93102832 | PKR Promotes Oxidative Stress and Apoptosis of Human Articular Chondrocytes by Causing Mitochondrial Dysfunction through p38 MAPK Activation-PKR Activation Causes Apoptosis in Human Chondrocytes |
| Q41602372 | PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes |
| Q38619034 | Paracrine Potential of the Human Adipose Tissue-Derived Stem Cells to Modulate Balance between Matrix Metalloproteinases and Their Inhibitors in the Osteoarthritic Cartilage In Vitro |
| Q51005767 | Platelet-activated serum might have a therapeutic effect on damaged articular cartilage. |
| Q47632345 | Potential role of rebamipide in osteoclast differentiation and mandibular condylar cartilage homeostasis |
| Q33820813 | Preliminary study on pain reduction of monosodium iodoacetate-induced knee osteoarthritis in rats by carbon dioxide laser moxibustion |
| Q89989274 | Promotion of G1/S Transition and Inhibition of Inflammatory Cytokine Production by Hydroxypyridinone-Coumarin in Osteoarthritis Rats |
| Q50872022 | Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13). |
| Q34610146 | Protective effects of biochanin A on articular cartilage: in vitro and in vivo studies |
| Q35683064 | Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes |
| Q41168681 | Role of MicroRNA in Osteoarthritis |
| Q47105118 | Saikosaponin A inhibits IL-1β-induced inflammatory mediators in human osteoarthritis chondrocytes by activating LXRα. |
| Q53554187 | Salutary effects of melatonin combined with treadmill exercise on cartilage damage. |
| Q41011694 | Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint. |
| Q91461179 | Sequestration of artemin reduces inflammation-induced activation and sensitization of bone marrow nociceptors in a rodent model of carrageenan-induced inflammatory bone pain |
| Q85604077 | Serum and synovial fluid C-reactive protein level variations in dogs with degenerative joint disease and their relationships with physiological parameters |
| Q46138417 | Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker |
| Q37696365 | Sesamin inhibits IL-1β-stimulated inflammatory response in human osteoarthritis chondrocytes by activating Nrf2 signaling pathway |
| Q35145099 | Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway |
| Q33755839 | Signaling pathways in cartilage repair |
| Q35592094 | Study of osteoarthritis treatment with anti-inflammatory drugs: cyclooxygenase-2 inhibitor and steroids |
| Q41623255 | Suppressive Effect of the n-Hexane Extract of Litsea japonica Fruit Flesh on Monosodium-Iodoacetate-Induced Osteoarthritis in Rats. |
| Q37608884 | Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. |
| Q36923621 | Syndecan-4 in intervertebral disc and cartilage: Saint or synner? |
| Q33679382 | Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation |
| Q34501230 | Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. |
| Q52656669 | Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells. |
| Q64276862 | The Importance of Physioxia in Mesenchymal Stem Cell Chondrogenesis and the Mechanisms Controlling Its Response |
| Q92442181 | The Inhibitory Effects of Slow-Releasing Hydrogen Sulfide Donors in the Mechanical Allodynia, Grip Strength Deficits, and Depressive-Like Behaviors Associated with Chronic Osteoarthritis Pain |
| Q33488093 | The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale |
| Q36613066 | The Role of miRNAs in Cartilage Homeostasis |
| Q36234739 | The antagonistic actions of endogenous interleukin-1β and 15-deoxy-Δ12,14-prostaglandin J2 regulate the temporal synthesis of matrix metalloproteinase-9 in sheared chondrocytes |
| Q35124848 | The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone. |
| Q38979165 | The danger from within: alarmins in arthritis |
| Q50996437 | The effect of vascular endothelial growth factor on aggrecan and type II collagen expression in rat articular chondrocytes. |
| Q38001412 | The osteoarthritic niche and modulation of skeletal stem cell function for regenerative medicine |
| Q39383794 | The phenotypic characterization of A13/BACii, a novel bovine chondrocytic cell line with differentiation potential |
| Q36617121 | The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. |
| Q97523968 | The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis |
| Q59812780 | The roles of prostaglandin F in regulating the expression of matrix metalloproteinase-12 via an insulin growth factor-2-dependent mechanism in sheared chondrocytes |
| Q42773924 | The synovial microenvironment of osteoarthritic joints alters RNA-seq expression profiles of human primary articular chondrocytes |
| Q34088913 | Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs |
| Q36745892 | To evaluate the effect of combining photo-activation therapy with platelet-rich plasma injections for the novel treatment of osteoarthritis. |
| Q41887934 | Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure |
| Q46224777 | Treatment of knee osteoarthritis with Orthokine-derived autologous conditioned serum |
| Q43429102 | Triterpene acids from rose hip powder inhibit self-antigen- and LPS-induced cytokine production and CD4⁺ T-cell proliferation in human mononuclear cell cultures |
| Q37631434 | Vitamin C Protects Chondrocytes against Monosodium Iodoacetate-Induced Osteoarthritis by Multiple Pathways. |
| Q36564183 | White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. |
| Q52920538 | [Degenerative DNA alterations in osteoarthritis]. |
| Q52629300 | miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway in rheumatoid arthritis. |
Search more.